$ELOX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eloxx Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Eloxx Pharmaceuticals, Inc.. Get notifications about new insider transactions in Eloxx Pharmaceuticals, Inc. for free.
Page: < prev 1 2 3 4 5 6 6 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 21 2013 | SVON | Sevion Therapeutic ... | Browne Leslie J | President and CEO | Buy | P | 0.04 | 30,000 | 1,200 | 49,000 | 19 K to 49 K (+157.89 %) |
May 20 2013 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.04 | 273,256 | 11,750 | 2,716,572 | |
May 20 2013 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.04 | 255,814 | 11,000 | 1,611,761 | |
May 20 2013 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.04 | 139,534 | 6,000 | 1,621,215 | |
May 20 2013 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.04 | 162,790 | 7,000 | 1,372,763 | |
May 20 2013 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.04 | 296,512 | 12,750 | 2,214,851 | |
May 20 2013 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.04 | 244,186 | 10,500 | 1,704,765 | |
May 20 2013 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.04 | 238,372 | 10,250 | 1,684,193 | |
Feb 20 2013 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.13 | 119,318 | 15,750 | 1,918,339 | |
Feb 20 2013 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.13 | 56,818 | 7,500 | 1,481,681 | |
Feb 20 2013 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.13 | 96,590 | 12,750 | 1,460,579 | |
Feb 20 2013 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.13 | 145,834 | 19,250 | 2,433,316 | |
Feb 20 2013 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.13 | 75,758 | 10,000 | 1,209,973 | |
Feb 20 2013 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.15 | 89,016 | 13,352 | 1,495,821 | |
Feb 20 2013 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.13 | 71,970 | 9,500 | 1,355,947 | |
Nov 26 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.16 | 2,500 | 400 | 12,757,318 | 12.8 M to 12.8 M (+0.02 %) |
Nov 26 2012 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.16 | 38,000 | 5,890 | 352,785 | 314.8 K to 352.8 K (+12.07 %) |
Nov 16 2012 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | A | 0.17 | 210,000 | 34,650 | 490,000 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP-Research | Option Exercise | A | 0.17 | 780,000 | 128,700 | 1,960,124 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.17 | 165,152 | 27,250 | 2,287,482 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.17 | 420,000 | 69,300 | 2,122,330 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.17 | 106,060 | 17,500 | 1,283,977 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.17 | 210,000 | 34,650 | 1,177,917 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | Browne Leslie J | CEO | Option Exercise | A | 0.17 | 1,365,000 | 225,225 | 3,458,550 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.17 | 77,272 | 12,750 | 1,424,863 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.17 | 294,000 | 48,510 | 1,347,591 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | CSO | Option Exercise | A | 0.17 | 780,000 | 128,700 | 1,823,276 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO, Secretary and ... | Option Exercise | A | 0.17 | 780,000 | 128,700 | 1,797,200 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.17 | 103,030 | 17,000 | 1,154,215 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.17 | 210,000 | 34,650 | 1,051,185 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.17 | 136,364 | 22,500 | 1,819,021 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.17 | 210,000 | 34,650 | 1,682,657 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.17 | 59,090 | 9,750 | 1,383,989 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.17 | 294,000 | 48,510 | 1,324,899 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.18 | 124,242 | 22,364 | 1,426,805 | |
Nov 16 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.18 | 252,000 | 45,360 | 1,302,563 | |
Oct 05 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | C | 0.26 | 1,000 | 260 | 0 | |
Oct 05 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | C | 0.26 | 4,292,583 | 1,116,072 | 12,754,818 | 8.5 M to 12.8 M (+50.73 %) |
Oct 05 2012 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | C | 0.26 | 200 | 52 | 0 | |
Oct 05 2012 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | C | 0.26 | 858,517 | 223,214 | 2,805,750 | 1.9 M to 2.8 M (+44.09 %) |
May 18 2012 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.21 | 34,146 | 7,000 | 841,185 | |
May 18 2012 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.21 | 46,342 | 9,500 | 1,702,330 | |
May 18 2012 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.21 | 31,708 | 6,500 | 967,917 | |
May 18 2012 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.21 | 10,976 | 2,250 | 1,053,591 | |
May 18 2012 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.21 | 40,244 | 8,250 | 1,472,657 | |
May 18 2012 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.21 | 10,976 | 2,250 | 1,030,899 | |
May 18 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.23 | 35,366 | 8,134 | 1,050,563 | |
Apr 13 2012 | SVON | Sevion Therapeutic ... | Klaver Paul Edward | 10% Owner | Gift | G | 0.00 | 3,000,000 | 0 | 10,146,527 | 7.1 M to 10.1 M (+41.98 %) |
Apr 13 2012 | SVON | Sevion Therapeutic ... | Klaver Paul Edward | 10% Owner | Gift | G | 0.00 | 3,000,000 | 0 | 7,146,527 | 10.1 M to 7.1 M (-29.57 %) |
Apr 13 2012 | SVON | Sevion Therapeutic ... | Klaver Paul Edward | 10% Owner | Gift | G | 0.00 | 2,000,000 | 0 | 10,146,527 | 8.1 M to 10.1 M (+24.55 %) |
Apr 13 2012 | SVON | Sevion Therapeutic ... | Klaver Paul Edward | 10% Owner | Gift | G | 0.00 | 2,000,000 | 0 | 8,146,527 | 10.1 M to 8.1 M (-19.71 %) |
Mar 30 2012 | SVON | Sevion Therapeutic ... | Browne Leslie J | President and CEO | Buy | P | 0.26 | 10,000 | 2,600 | 19,000 | 9 K to 19 K (+111.11 %) |
Feb 24 2012 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.24 | 15,626 | 3,750 | 1,042,615 | |
Feb 24 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.26 | 36,458 | 9,479 | 1,015,197 | |
Feb 24 2012 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.24 | 29,166 | 7,000 | 767,039 | |
Feb 24 2012 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.24 | 15,626 | 3,750 | 1,019,923 | |
Feb 24 2012 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.24 | 40,626 | 9,750 | 1,432,413 | |
Feb 24 2012 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.24 | 45,834 | 11,000 | 1,655,988 | |
Feb 24 2012 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.24 | 20,834 | 5,000 | 936,209 | |
Jan 19 2012 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.26 | 192,308 | 50,000 | 8,239,021 | 8 M to 8.2 M (+2.39 %) |
Jan 19 2012 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | P | 0.26 | 961,538 | 250,000 | 1,902,590 | 941.1 K to 1.9 M (+102.18 %) |
Dec 08 2011 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.24 | 44,039 | 10,402 | 314,785 | 270.7 K to 314.8 K (+16.27 %) |
Nov 16 2011 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.20 | 62,500 | 12,500 | 817,873 | |
Nov 16 2011 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.20 | 82,500 | 16,500 | 1,026,989 | |
Nov 16 2011 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.20 | 82,500 | 16,500 | 1,004,297 | |
Nov 16 2011 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.22 | 87,500 | 19,250 | 1,018,739 | |
Nov 16 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.20 | 147,500 | 29,500 | 1,610,154 | |
Nov 16 2011 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.20 | 105,000 | 21,000 | 1,646,787 | |
Nov 16 2011 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.20 | 80,000 | 16,000 | 915,375 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.23 | 230,000 | 52,900 | 944,489 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.25 | 190,000 | 47,500 | 931,239 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | EVP and CSO | Option Exercise | A | 0.23 | 468,000 | 107,640 | 1,263,676 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | A | 0.23 | 155,000 | 35,650 | 280,000 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.23 | 155,000 | 35,650 | 1,316,787 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.23 | 155,000 | 35,650 | 835,375 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | Browne Leslie J | President and CEO | Option Exercise | A | 0.23 | 819,000 | 188,370 | 0 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO, Secretary and ... | Option Exercise | A | 0.23 | 468,000 | 107,640 | 1,325,500 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 0.23 | 468,000 | 107,640 | 1,460,924 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.23 | 155,000 | 35,650 | 755,373 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.23 | 230,000 | 52,900 | 921,797 | |
Oct 04 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.23 | 305,000 | 70,150 | 1,462,654 | |
May 19 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.27 | 51,852 | 14,000 | 1,157,654 | |
Jun 14 2011 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.27 | 20,000 | 5,400 | 270,746 | 250.7 K to 270.7 K (+7.98 %) |
May 19 2011 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.27 | 32,408 | 8,750 | 680,375 | |
May 19 2011 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.27 | 48,148 | 13,000 | 1,161,787 | |
May 19 2011 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.27 | 27,778 | 7,500 | 691,797 | |
May 19 2011 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.27 | 28,704 | 7,750 | 600,373 | |
May 19 2011 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.30 | 37,962 | 11,389 | 741,239 | |
May 19 2011 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.27 | 27,778 | 7,500 | 714,489 | |
Mar 23 2011 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | P | 0.28 | 15,000 | 4,191 | 7,452,289 | 7.4 M to 7.5 M (+0.20 %) |
Mar 22 2011 | SVON | Sevion Therapeutic ... | Browne Leslie J | President and CEO | Buy | P | 0.27 | 3,000 | 805 | 9,000 | 6 K to 9 K (+50.00 %) |
Feb 24 2011 | SVON | Sevion Therapeutic ... | Browne Leslie J | President and CEO | Buy | P | 0.29 | 3,000 | 865 | 6,000 | 3 K to 6 K (+100.00 %) |
Feb 24 2011 | SVON | Sevion Therapeutic ... | Browne Leslie J | President and CEO | Buy | P | 0.29 | 3,000 | 857 | 3,000 | 0 to 3 K |
Feb 16 2011 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.32 | 32,758 | 10,483 | 703,277 | |
Feb 16 2011 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.29 | 18,104 | 5,250 | 686,711 | |
Feb 16 2011 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.29 | 29,310 | 8,500 | 571,669 | |
Feb 16 2011 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.29 | 18,104 | 5,250 | 664,019 | |
Feb 16 2011 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.29 | 32,758 | 9,500 | 647,967 | |
Feb 16 2011 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.29 | 31,896 | 9,250 | 1,113,639 | |
Feb 16 2011 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.29 | 45,690 | 13,250 | 1,105,802 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.26 | 150,000 | 39,000 | 668,607 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Option Exercise | A | 0.26 | 49,038 | 12,750 | 518,607 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.29 | 67,308 | 19,519 | 670,519 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | A | 0.29 | 125,000 | 36,250 | 603,211 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Option Exercise | A | 0.26 | 100,000 | 26,000 | 125,000 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.26 | 100,000 | 26,000 | 542,359 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Option Exercise | A | 0.26 | 71,154 | 18,500 | 442,359 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.26 | 150,000 | 39,000 | 645,915 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Option Exercise | A | 0.26 | 43,269 | 11,250 | 495,915 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.26 | 100,000 | 26,000 | 1,081,743 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Option Exercise | A | 0.26 | 71,792 | 18,666 | 981,743 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 500,000 | 130,000 | 1,060,112 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 200,000 | 52,000 | 560,112 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | A | 0.26 | 96,154 | 25,000 | 360,112 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | BROOKS JOEL | CFO and Treasurer | Option Exercise | A | 0.26 | 425,000 | 110,500 | 882,500 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Browne Leslie J | President and CEO | Option Exercise | A | 0.26 | 725,000 | 188,500 | 1,725,000 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Dondero Richard S | VP - Research and D ... | Option Exercise | A | 0.26 | 425,000 | 110,500 | 1,232,924 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.26 | 50,000 | 13,000 | 615,209 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.26 | 50,000 | 13,000 | 565,209 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.26 | 100,000 | 26,000 | 515,209 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Option Exercise | A | 0.26 | 37,177 | 9,666 | 415,209 | |
Nov 19 2010 | SVON | Sevion Therapeutic ... | THOMPSON JOHN PHD | EVP and CSO | Option Exercise | A | 0.26 | 425,000 | 110,500 | 995,676 | |
Jun 03 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | P | 0.32 | 1,000 | 320 | 1,000 | |
Jun 03 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Option Exercise | P | 0.35 | 3,125,000 | 1,093,750 | 7,091,477 | |
Jun 03 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.32 | 200 | 64 | 200 | |
Jun 03 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Option Exercise | P | 0.35 | 625,000 | 218,750 | 1,167,333 | |
May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Buy | C | 0.83 | 631,176 | 523,876 | 822,168 | 191 K to 822.2 K (+330.47 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Grant | A | 0.51 | 12,078 | 6,202 | 190,992 | 178.9 K to 191 K (+6.75 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Waksal Harlan | Director | Grant | A | 0.37 | 28,135 | 10,334 | 178,914 | 150.8 K to 178.9 K (+18.66 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Buy | C | 0.83 | 77,840 | 64,607 | 137,964 | 60.1 K to 138 K (+129.47 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Grant | A | 0.51 | 1,487 | 764 | 60,124 | 58.6 K to 60.1 K (+2.54 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | BRACA JOHN N | Director | Grant | A | 0.37 | 3,470 | 1,275 | 58,637 | 55.2 K to 58.6 K (+6.29 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Buy | C | 0.83 | 4,101,800 | 3,404,494 | 7,407,289 | 3.3 M to 7.4 M (+124.09 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Grant | A | 0.51 | 78,469 | 40,294 | 3,305,489 | 3.2 M to 3.3 M (+2.43 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | FORBES CHRISTOPHER | Director | Grant | A | 0.37 | 182,840 | 67,157 | 3,227,020 | 3 M to 3.2 M (+6.01 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Buy | C | 0.83 | 77,840 | 64,607 | 101,764 | 23.9 K to 101.8 K (+325.36 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Grant | A | 0.51 | 1,487 | 764 | 23,924 | 22.4 K to 23.9 K (+6.63 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Isabelle Warren John | Director | Grant | A | 0.37 | 3,470 | 1,275 | 22,437 | 19 K to 22.4 K (+18.29 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Buy | C | 0.83 | 631,176 | 523,876 | 1,053,938 | 422.8 K to 1.1 M (+149.30 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Grant | A | 0.51 | 12,078 | 6,202 | 422,762 | 410.7 K to 422.8 K (+2.94 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | STALDER RUEDI | Director | Grant | A | 0.37 | 28,135 | 10,334 | 410,684 | 382.5 K to 410.7 K (+7.35 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.52 | 4,694 | 2,441 | 250,746 | 246.1 K to 250.7 K (+1.91 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | P | 0.51 | 15,306 | 7,860 | 246,052 | 230.7 K to 246.1 K (+6.63 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Buy | C | 0.83 | 159,063 | 132,022 | 230,746 | 71.7 K to 230.7 K (+221.90 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Grant | A | 0.51 | 3,042 | 1,562 | 71,683 | 68.6 K to 71.7 K (+4.43 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | RECTOR DAVID | Director | Grant | A | 0.37 | 7,090 | 2,604 | 68,641 | 61.6 K to 68.6 K (+11.52 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Buy | C | 0.83 | 30,459 | 25,281 | 40,068 | 9.6 K to 40.1 K (+316.98 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Grant | A | 0.51 | 588 | 302 | 9,609 | 9 K to 9.6 K (+6.52 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | Van Hulst Jack | Director | Grant | A | 0.37 | 1,358 | 499 | 9,021 | 7.7 K to 9 K (+17.72 %) |
May 27 2010 | SVON | Sevion Therapeutic ... | QUICK THOMAS C | Director | Buy | C | 0.83 | 314,742 | 261,236 | 814,907 | 500.2 K to 814.9 K (+62.93 %) |